News UK scientists say they have found cancer driver in junk DNA It has suspected for many years that some diseases may be linked to non-coding or 'junk' DNA, but the mechanism behind the pathology hasn't been worked out.
News ProNAi licenses new DNA damage cancer treatment Candidate takes novel approach to targeting DNA damage response
News Acquisitive Lilly offers $2.88bn for Merida Bio Lilly has continued its lengthy streak of acquisitions in 2026 with a $2.88 billion agreement to buy immunology and inflammation specialist Merida.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.